4D Molecular Therapeutics, Inc. (FDMT) Analyst Forecast

$6.35

north_east
$0.42 (7.08%)
Day's range
$5.86
Day's range
$6.65

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/11/2025 Morgan Stanley Judah Frommer $6.00 $5.52   8.7%
09/19/2024 BMO Capital Kostas Biliouris $40.00 $13.28   201.2%
09/19/2024 Loop Capital Markets Geulah Livshits $39.00 $13.31   192.99%
09/19/2024 H.C. Wainwright Matthew Caufield $36.00 $13.31   170.44%
04/15/2024 RBC Capital Lisa Walter $40.00 $26.35   51.8%
04/14/2024 Barclays Gena Wang $45.00 $26.35   70.78%
04/01/2024 Jefferies Nalin Tejavibulya $58.00 $31.86   82.05%
03/28/2024 BMO Capital Kostas Biliouris $63.00 $31.59   99.43%
02/06/2024 BMO Capital Kostas Biliouris $70.00 $30.71   127.98%
07/05/2023 Chardan Capital Geulah Livshits $30.00 $18.43   62.78%

4D Molecular Therapeutics, Inc. FAQ's

4D Molecular Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, Loop Capital Markets, H.C. Wainwright, RBC Capital, Barclays in the past 90 days.